Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/26/2009 | US20090291474 Collagen-like polypeptides and encoding polynucleotides |
11/26/2009 | US20090291472 Influenza nucleic acids, polypeptides, and uses thereof |
11/26/2009 | US20090291471 Novel Beta-Galactoside Alpha 2,6-Sialyltransferase, Gene Coding For The Transferase And Process For Producing The Same |
11/26/2009 | US20090291470 Chondroitin synthase, method for producing the same and method for producing saccharide chain-extended chondroitin |
11/26/2009 | US20090291469 Compositions and Methods for Producing Fermentation Products and Residuals |
11/26/2009 | US20090291455 Cynomolgus gp80 Receptor and Uses |
11/26/2009 | US20090291450 Caterpiller gene family |
11/26/2009 | US20090291441 Polypeptide, nucleic acid molecule encoding it and their uses |
11/26/2009 | US20090291439 Phosphatases involved in the regulation of cardiomyocyte differentiation |
11/26/2009 | US20090291436 Methods for detecting nucleic acids indicative of cancer |
11/26/2009 | US20090291432 Genetic profiles associated with the 957C>T polymorphism in the DRD2 gene |
11/26/2009 | US20090291429 Substances causing differentiation |
11/26/2009 | US20090291193 Cereals with Altered Dormancy |
11/26/2009 | US20090291145 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
11/26/2009 | US20090291131 Silencing of polo-like kinase expression using interfering rna |
11/26/2009 | US20090291104 Novel conotoxin framework with a helix-loop-helix fold |
11/26/2009 | US20090291094 Antibodies and processes for preparing the same |
11/26/2009 | US20090291090 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
11/26/2009 | US20090291084 Anti- il-6 antibodies, compositions, methods and uses |
11/26/2009 | US20090291081 Dual-specific IL-1A/IL-1b antibodies |
11/26/2009 | US20090291063 Compositions and methods for the treatment of viral hepatitis |
11/26/2009 | DE102008025008A1 Insulin analogs which comprise A chain and B chain with disulfide bonds for use in treatment of diabetes |
11/26/2009 | DE102008025007A1 Insulin analogs which comprise A chain and B chain with disulfide bonds for use in treatment of diabetes and for cartilage regeneration |
11/26/2009 | DE102008024778A1 Verwendung von pektinolytischen Enzymen zur Behandlung von Obst- und Gemüsemaische und Enzymsequenzen dazu Use of pectinolytic enzymes for the treatment of fruit and vegetables and mash enzyme sequences to |
11/26/2009 | DE102008001874A1 Verfahren zur Herstellung von L-Aminosäuren A method for producing L-amino acids |
11/26/2009 | DE102007009347B4 Verfahren zur Isolierung von Nukleinsäuren A process for the isolation of nucleic acids |
11/26/2009 | CA2726736A1 Composition and method for determining esophageal cancer |
11/26/2009 | CA2725528A1 Use of a chimeric gene 4-cl encoding 4-coumarate: coa ligase in brassicaceae |
11/26/2009 | CA2725526A1 Anti-tumoral cells |
11/26/2009 | CA2725289A1 Influenza cap-leader sequence |
11/26/2009 | CA2725198A1 Novel soluble cd83 polypeptides, formulations and methods of use |
11/26/2009 | CA2725175A1 Production of squalene using yeast |
11/26/2009 | CA2725169A1 Method of generating single vl domain antibodies in transgenic animals |
11/26/2009 | CA2725162A1 An adapter molecule for the delivery of adenovirus vectors |
11/26/2009 | CA2724995A1 Reduction of lyso-phosphatidylcholine acyltransferase activity |
11/26/2009 | CA2724982A1 Histamine binding protein |
11/26/2009 | CA2724700A1 Herg mutants and uses thereof |
11/26/2009 | CA2724545A1 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny |
11/26/2009 | CA2724419A1 Transgenic sugar beet plants |
11/26/2009 | CA2723618A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody |
11/26/2009 | CA2723427A1 Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
11/26/2009 | CA2723263A1 Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides |
11/26/2009 | CA2722461A1 Dgat genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
11/26/2009 | CA2722458A1 Dgat genes from yarrowia lipolytica combined with plastidic phosphoglucomutase down regulation for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
11/26/2009 | CA2720664A1 Novel compositions which inhibit melanogenesis and uses thereof |
11/26/2009 | CA2698582A1 Peptide having an extending action for half-life of object peptide in plasma |
11/26/2009 | CA2667177A1 Slpa as a tool for recombinant protein and enzyme technology |
11/25/2009 | EP2123772A1 Beta-lactam antibiotic producing strains |
11/25/2009 | EP2123764A1 The rice actin 2 promoter and intron and methods for use thereof |
11/25/2009 | EP2123763A1 Compositions and methods of increasing stress tolerance in plants |
11/25/2009 | EP2123762A2 Tandem repeat DNA constructs producing proteins that attack plant pathogenic viruses, fungi, and bacteria by disrupting transcription factors essential for replication thereof in plants |
11/25/2009 | EP2123761A2 Rhamnose promoter expression system |
11/25/2009 | EP2123760A1 Enzymatic method for enantioselective reduction of keto compounds |
11/25/2009 | EP2123759A2 Stabilized RNAS as transfection controls and silencing reagents |
11/25/2009 | EP2123758A1 Influenza cap-leader sequence |
11/25/2009 | EP2123757A1 5` triphosphate oligonucleotide with blunt end and uses thereof |
11/25/2009 | EP2123756A1 Transglutaminase having disulfide bond introduced therein |
11/25/2009 | EP2123755A1 Attenuated minus-stranded rna virus |
11/25/2009 | EP2123754A1 CHIMERIC Fc RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
11/25/2009 | EP2123753A1 Plant having increased yield of seeds |
11/25/2009 | EP2123752A2 Novel nucleic acid |
11/25/2009 | EP2123751A1 Novel peptide |
11/25/2009 | EP2123750A1 Novel protein having acyltransferase activity and gene encoding the same |
11/25/2009 | EP2123749A2 Novel genes encoding novel proteolytic enzymes |
11/25/2009 | EP2123746A2 Gene inactivated mutants with altered protein production |
11/25/2009 | EP2123680A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
11/25/2009 | EP2123676A1 Diagnosis and treatment of cancer by using anti-prg-3 antibody |
11/25/2009 | EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor |
11/25/2009 | EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses |
11/25/2009 | EP2123671A1 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease |
11/25/2009 | EP2121982A2 Maize plants characterised by quantitative trait loci (qtl) |
11/25/2009 | EP2121954A2 Coryneform bacteria with formate-thf-synthetase and/or glycine cleavage activity |
11/25/2009 | EP2121953A1 A method for producing an l-amino acid by fermentation using a bacterium having an enhanced ability to utilize glycerol |
11/25/2009 | EP2121943A2 Composition and method for enhancing cell growth and cell fusion |
11/25/2009 | EP2121941A2 Tobacco plants having reduced nicotine demethylase activity |
11/25/2009 | EP2121940A1 Peroxidase gene nematode inducible promotors and methods of use |
11/25/2009 | EP2121939A2 Methods and compositions for modulating the sirna and rna-directed-dna methylation pathways |
11/25/2009 | EP2121938A2 Maize microrna sequences |
11/25/2009 | EP2121937A2 Regulation of plant metabolism |
11/25/2009 | EP2121936A2 Plants with increased yield |
11/25/2009 | EP2121935A1 Transcriptional repressors of cytokinin signaling and their use |
11/25/2009 | EP2121934A2 Production of arachidonic acid in oilseed plants |
11/25/2009 | EP2121933A1 Use of alanine racemase genes to confer nematode resistance to plants |
11/25/2009 | EP2121932A1 Genetically modified plants which synthesize a low amylose starch with increased swelling power |
11/25/2009 | EP2121931A1 Purification of fc-tact fusion proteins using the oilbody technology |
11/25/2009 | EP2121930A1 Neurotrophic peptides |
11/25/2009 | EP2121929A2 Targeted delivery of sirna |
11/25/2009 | EP2121928A2 Use of double stranded rna hairpin duplexes in gene silencing |
11/25/2009 | EP2121927A2 A sequence of dsrna: atn-rna, intervention using irnai, use of a sequence of dsrna: atn-rna, a method of treating and inhibiting a brain tumor, a kit for inhibiting cancer cell which expresses tenascin, a method for a kit preparation in a brain tumor therapy |
11/25/2009 | EP2121926A1 Nucleic acid compounds for inhibiting wnt gene expression and uses thereof |
11/25/2009 | EP2121924A1 Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof |
11/25/2009 | EP2121922A2 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered |
11/25/2009 | EP2121921A2 Novel genes and rna molecules that confer stress tolerance |
11/25/2009 | EP2121919A2 Mutant g-protein coupled receptors and methods for selecting them |
11/25/2009 | EP2121918A1 L-threonine overproducing microorganism and method for preparing l-threonine using the same |
11/25/2009 | EP2121917A2 Cell line having a high transcription activity for the production of proteins, in particular therapeutic proteins |
11/25/2009 | EP2121916A1 Assays for improved fungal strains |
11/25/2009 | EP2121915A2 Materials and methods for efficient succinate and malate production |
11/25/2009 | EP2121914A2 Mitochondrial nucleic acid delivery systems |
11/25/2009 | EP2121908A1 Truncated alternansucrase coding nucleic acid molecules |